Marco Dionisi

837 total citations
7 papers, 612 citations indexed

About

Marco Dionisi is a scholar working on Pharmacology, Molecular Biology and Immunology. According to data from OpenAlex, Marco Dionisi has authored 7 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 2 papers in Molecular Biology and 2 papers in Immunology. Recurrent topics in Marco Dionisi's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Neutropenia and Cancer Infections (1 paper). Marco Dionisi is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Glycosylation and Glycoproteins Research (1 paper) and Neutropenia and Cancer Infections (1 paper). Marco Dionisi collaborates with scholars based in Italy, Germany and Denmark. Marco Dionisi's co-authors include Giovanni Martinelli, Bernardino Allione, Daniela Cilloni, A. Del Favero, Francesco Fabbiano, Pietro Martino, Annamaria Nosari, Giorgina Specchia, Giampaolo Bucaneve and Alessandra Micozzi and has published in prestigious journals such as New England Journal of Medicine, International Journal of Molecular Sciences and Frontiers in Immunology.

In The Last Decade

Marco Dionisi

7 papers receiving 600 citations

Peers

Marco Dionisi

ONCOL

CB

EPIDE

PHARM

GENET

Tattersall Mh Australia

Laura Jiménez Spain

Steven J. Ketchel United States

S. C. Schimpff United States

Nicole Blijlevens Netherlands

Davis M. Hahn United States

V. Rodríguez United States

Marie‐Claude Gagnieu France

Naoki Matsumura Japan

Alan T. Davis United States

Tattersall Mh Australia

Marco Dionisi

306 ×0.7

ONCOL

174 ×1.0

CB

88 ×0.6

EPIDE

119 ×0.9

PHARM

34 ×0.4

GENET

Citations per year, relative to Marco Dionisi Marco Dionisi (= 1×) peers Tattersall Mh

Countries citing papers authored by Marco Dionisi

Since Specialization

Citations

This map shows the geographic impact of Marco Dionisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Dionisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Dionisi more than expected).

Fields of papers citing papers by Marco Dionisi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Dionisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Dionisi. The network helps show where Marco Dionisi may publish in the future.

Co-authorship network of co-authors of Marco Dionisi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Dionisi. A scholar is included among the top collaborators of Marco Dionisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Dionisi. Marco Dionisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Dionisi, Marco, Sara Cairoli, Raffaele Simeoli, et al.. (2021). Pharmacokinetic Evaluation of Eltrombopag in ITP Pediatric Patients. Frontiers in Pharmacology. 12. 772873–772873. 4 indexed citations

2.

Napoletano, Chiara, Zilu Ye, Hassan Rahimi, et al.. (2020). Investigating Patterns of Immune Interaction in Ovarian Cancer: Probing the O-glycoproteome by the Macrophage Galactose-Like C-Type Lectin (MGL). Cancers. 12(10). 2841–2841. 14 indexed citations

3.

Cairoli, Sara, Raffaele Simeoli, Marco Dionisi, et al.. (2020). A new HPLC–DAD method for contemporary quantification of 10 antibiotics for therapeutic drug monitoring of critically ill pediatric patients. Biomedical Chromatography. 34(10). e4880–e4880. 24 indexed citations

4.

Rose, Domenico Umberto De, Sara Cairoli, Marco Dionisi, et al.. (2020). Therapeutic Drug Monitoring Is a Feasible Tool to Personalize Drug Administration in Neonates Using New Techniques: An Overview on the Pharmacokinetics and Pharmacodynamics in Neonatal Age. International Journal of Molecular Sciences. 21(16). 5898–5898. 31 indexed citations

5.

Dionisi, Marco, Francesca Belleudi, Ilaria Grazia Zizzari, et al.. (2018). Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells. Frontiers in Immunology. 9. 2481–2481. 31 indexed citations

6.

Bucaneve, Giampaolo, Alessandra Micozzi, Francesco Menichetti, et al.. (2005). Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia. New England Journal of Medicine. 353(10). 977–987. 454 indexed citations

7.

Patoia, L., Luca Santucci, P. Furno, et al.. (1996). A 4-Week, Double-Blind, Parallel-Group Study to Compare the Gastrointestinal Effects of Meloxicam 7.5 mg, Meloxicam 15 mg, Piroxicam 20 mg and Placebo by Means of Faecal Blood Loss, Endoscopy and Symptom Evaluation in Healthy Volunteers. Lara D. Veeken. 35(suppl 1). 61–67. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact